| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.15▼ | 1.16▼ | 1.16▼ | 1.17▼ | 1.26▼ |
| MA10 | 1.18▼ | 1.20▼ | 1.21▼ | 1.22▼ | 2.13▼ |
| MA20 | 1.24▼ | 1.24▼ | 1.24▼ | 1.28▼ | 1.36▼ |
| MA50 | 1.29▼ | 1.30▼ | 1.32▼ | 2.26▼ | 0.75▲ |
| MA100 | 1.34▼ | 1.35▼ | 1.37▼ | 1.30▼ | 1.68▼ |
| MA200 | 1.38▼ | 1.96▼ | 2.52▼ | 0.81▲ | 8.18▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | -0.010▼ | -0.010▼ | 0.028▲ | -0.127▼ |
| RSI | 34.730▼ | 34.124▼ | 34.334▼ | 34.760▼ | 48.452▼ |
| STOCH | 33.801 | 31.277 | 30.424 | 40.689 | 11.997▼ |
| WILL %R | -76.000▼ | -76.000▼ | -76.000▼ | -68.421 | -86.115▼ |
| CCI | -66.667 | -69.039 | -75.730 | -84.614 | -39.975 |
| CDL | $OGEN Engulfing Candlestick Pattern Detected | Set Alert |
|
Monday, August 11, 2025 12:25 PM
Oragenics (NYSE American: OGEN) , a biotechnology company developing brain-targeted therapeutics via proprietary intranasal delivery technology, repo ...
|
|
Monday, August 11, 2025 05:54 AM
Advancing Brain-First Recovery Platform Toward Clinical MilestonesPioneering Intranasal Therapeutics for Concussion SARASOTA, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: ...
|
|
Friday, August 08, 2025 01:55 PM
Oragenics Inc. OGEN) on Friday reported a loss of $2.3 million in its second quarter.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 1.20 | 1.20 | 1.13 | 1.15 | 73,208 |
| 14/08/25 | 1.18 | 1.19 | 1.13 | 1.19 | 80,222 |
| 13/08/25 | 1.16 | 1.17 | 1.1301 | 1.15 | 133,114 |
| 12/08/25 | 1.17 | 1.1999 | 1.14 | 1.17 | 129,602 |
| 11/08/25 | 1.16 | 1.18 | 1.1598 | 1.17 | 120,146 |
| 08/08/25 | 1.30 | 1.35 | 1.03 | 1.16 | 438,800 |
| 07/08/25 | 1.30 | 1.33 | 1.2903 | 1.30 | 74,164 |
| 06/08/25 | 1.27 | 1.34 | 1.26 | 1.31 | 115,600 |
| 05/08/25 | 1.25 | 1.34 | 1.25 | 1.32 | 98,852 |
| 04/08/25 | 1.26 | 1.28 | 1.25 | 1.26 | 67,600 |
|
|
||||
|
|
||||
|
|